These mice, which express both the Arctic and Swedish AβPP mutations (21), display early intraneuronal Aβ accumulation and protofibril formation prior to the appearance of plaque pathology, with amyloid plaques that are as difficult to dissolve as those found in human AD (22, 23). The gene discussed is APP; the disease is Alzheimer disease.